Oncology Letters and Numbers Flashcards
Chro 17q mutation
BRCA1: dsDNA repair
Chro 13q mutation
BRCA2: dsDNA repair
Chro 17 EGFR overexpression
HER2
E-Cadherin +
Invasive Ductal Carcinoma
E-Cadherin -
Lobar Carcinoma
p53 inactive, kras active, EGFR mutation (activates kras), EML4&ALK Chimera
Lung Cancer
AK53
colon cancer (inactivates APC)
APC
colon cancer (inactivates APC)
Wnt
colon cancer (how APC blocks growth)
MLH1 & 2
decreased in lynch
BRAF mutation
lynch
MiB1/Ki67+
adenomatous polyp (proliferation)
p16/CDKN2a
Pancreatic ductal adenocarcinoma (leads to TP53, SMAD)
TP53
pancreatic ductal adenocarcinoma
SMAD4
pancreatic ductal adenocarcinoma
hMLH1
pancreatic ductal adenocarcinoma (familial, 5%)
hSMH2
pancreatic ductal adenocarcinoma (familial, 5%)
CDH1/E-cadherin mutations
diffuse gastric cancer (AD inheritance)
E6
degrades p53 (HPV16,18)
E7
increases DNA synth (HPV16, 18)
16, 18, 6, 11
Gardasil HPV strains
MLH1, MSH2/6. PMS2, PTEN
uterine cancer (HNPCC/Lynch, p53 loss etc)
LDH
dysgerminoma (uterine germ cell)
hCG
choriocarcinoma (uterine germ cell)
AFP
yolk sac tumor (uterine germ cell)
VHL mutation
clear cell renal carcinoma
HPRC (MET path) or HGLRCC
papillary renal cell carcinoma
HIF
almost all renal cell carcinoma
Chr 3p loss
clear cell renal carcinoma (VHL)
Chro 7 & 17 trisomy
papillary renal cell carcinoma (HPRC/HGLRCC)
loss of chro 1,6,19
chromophobe RCC (best prog)
LOF in Wt1 (11p13)
wilms tumor/nephroblastoma (from denys-drash or mutation)
increased APF and/or betaHCG +/- LDH
Non-seminomatous testicular cancer
increased betaHCG +/- LDH
seminomatous testicular cancer
Loss of GSTP1
PTEN/p53/Rb/Myc loss (testicular cancer
loss of p16
squamous cell carcinoma
p16 overexpression
HPV SCC (nonkeratinizing, better prog)
EWS-FLI1
ewings sarcoma, tx chemo
C-KIT mutation
GI stromal tumor, tx imatinib
T(8;21)(15;17), inv(16)
good AML prog
5q, chemo, complex karyotype
bad AML prog
T(15;17), PML/RARa fusion transcript
APL (AML M3)
Tdt+, Ig+, CD10+
B-cell ALL
Tdt+, CD2+, CD3+
T-cell ALL
T(9;22)
philly! Bad ALL (>60)
T(4;11)
bad ALL (<1)
del (5q31) leads to del (RPS14)
5q (MDS subtype)
JAK2V617F
polycythemia vera (92%)
JAK2 mut
essential thrombocytosis (42%)
CALR better prog than JAK2
primary myelofibrosis
MR3 (major) >3 log BCR-ABL reduction, MR4.5 (complete) >4.5
CML
T(9;22) BCR-ABL fusion
CML (increased TK activity)
CD20+***, CD5+
CLL
13q-
good CLL prog (-13q14 is intermediate MM)
11q-, 17p-
Bad CLL prog
CD19+, CD20+, CD10+, BC16+ (germinal center markers)
DLBCL
BCL6 overexpression
GC type DLBCL
NFkP addition
Non-GC DLBCL
CD30 mutation
Type 3 (primary mediastinal) BCL
IgM, CD19+, CD20+, CD10+, BC16+ (germinal center markers), NEVER Bcl12
burkitt’s lymphoma
C-myc translocation from t(8;14), t (8;22) or t(2;8)
+EBV! Burkitt’s lymphoma
CD5+, Cyclin D1+
mantle zone lymphoma
transloaction of cyclin D1 (11) and heavy-chain Ig (14)
mantle zone lymphoma
Ki67
levels=prog for mantle cell (blastic is worst, leukemic is best)
CD19+, CD20+, but no CD10
MALT (extra-nodal marginal zone lymphoma)
increased NfkB
MALT (extra-nodal marginal zone lymphoma)
ALK+
good prog in Anaplastic Large Cell lymphome
CD30+
Anaplastic Large Cell Lymphoma, tx: brentuximab
T(2;5) mutation
younger better Anaplastic Large Cell Lymphoma
Bc16, CD10, but NO CD2,3,5,7
Angioblastic T-Cell Lymphoma
Coombs- anemia, gamma/delta TCR rearrangement
hepatosplenic t-cell lymphoma
alpha/beta TCR rearrangement, CD3, CD8, NO NKs (CD56-)
subcutaneous panniculitis-like lymphoma
TAX+. CD4+, CD25+
Adult T-cell Lymphoma (HTLV1)
HTLV-1
virus, causes Adult T-cell lymphoma (Caribbean)
PAX+, CD15+, CD30+
hodgkins
CD20+, CD30(=)
+cervical LAD! Lymph-prominent Hodgkins
CD38+ (kappa/gamma restricted)
+Mott, Dutcher: MM
T(4;14)(p16;q32), t(14;16)(q32;q23), and -p53 (-17p13)
Bad MM prog
13q14 deletion
intermediate MM prog (13- is good CLL)